Article Details
Retrieved on: 2025-09-02 18:01:03
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Investors seem excited about the prospect of this early-stage menin inhibitor, with New Enterprise Associates partner Matthew McAviney noting that ...
Article found on: www.pharmaceutical-technology.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here